These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31900854)

  • 21. CRISPR Gene Drive Efficiency and Resistance Rate Is Highly Heritable with No Common Genetic Loci of Large Effect.
    Champer J; Wen Z; Luthra A; Reeves R; Chung J; Liu C; Lee YL; Liu J; Yang E; Messer PW; Clark AG
    Genetics; 2019 May; 212(1):333-341. PubMed ID: 30918006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Accelerated Gene Drives Pump the Brakes.
    LeMieux J
    CRISPR J; 2019 Aug; 2():196-198. PubMed ID: 31436503
    [No Abstract]   [Full Text] [Related]  

  • 25. Germline Editing: Editors Cautionary.
    Krishan K; Kanchan T; Singh B; Baryah N; Puri S
    Clin Ter; 2018; 169(2):e58-e59. PubMed ID: 29595865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    Musunuru K
    J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics assessment in research proposals adopting CRISPR technology.
    Hirsch F; Iphofen R; Koporc Z
    Biochem Med (Zagreb); 2019 Jun; 29(2):020202. PubMed ID: 31223254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 31. The ethical landscape of gene drive research.
    Callies DE
    Bioethics; 2019 Nov; 33(9):1091-1097. PubMed ID: 31389027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective.
    Zhang D; Hussain A; Manghwar H; Xie K; Xie S; Zhao S; Larkin RM; Qing P; Jin S; Ding F
    Plant Biotechnol J; 2020 Aug; 18(8):1651-1669. PubMed ID: 32271968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
    Alagoz M; Kherad N
    Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
    Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. He Jiankui´s gene-editing experiment and the non-identity problem.
    Alonso M; Savulescu J
    Bioethics; 2021 Jul; 35(6):563-573. PubMed ID: 33951203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
    Tomlinson T
    Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome Editing for Longer Lives: The Problem of Loneliness.
    Wareham CS
    J Bioeth Inq; 2020 Jun; 17(2):309-314. PubMed ID: 32152896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.